Success Stories: Fighting Blood Cancer with Precision: Assistant Professor in Clinical Immunotherapy Medicine Granted NIW with Strategic Help from NAILG

Client’s Testimonial:

“I am sincerely grateful to NAILG for their expert guidance and strategic support throughout my NIW petition process. Their team demonstrated a strong understanding of my work and presented it effectively to meet USCIS standards. The petition was ultimately approved in just over a month with premium processing. While communication was highly responsive and thorough during most of the process, I did notice some delays toward the final stages. Nonetheless, I appreciate their dedication and would recommend NAILG to others pursuing an NIW.”

On May 13^th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Hospitalist/Clinical Assistant Professor in the Field of Clinical Immunotherapy Medicine (Approval Notice).

General Field: Clinical Immunotherapy Medicine

Position at the Time of Case Filing: Hospitalist/Clinical Assistant Professor

Country of Origin: China

State of Residence at the Time of Filing: Pennsylvania

Approval Notice Date: May 13^th, 2025

Processing Time: 1 month, 10 days (Premium Processing Requested)

Case Summary:

An assistant professor stands at the forefront of clinical immunotherapy, merging laboratory innovation with patient-centered treatment for blood cancers. His proposed endeavor focuses on enhancing CAR-T cell therapy for hematological malignancies by integrating high-impact research with compassionate, trial-based care. His goal is to close the translational gap – bringing discoveries out of the lab and into the hands of clinicians, where they can improve lives.

As an expert in personalized medicine and immune cell engineering, our client plays a vital role in reshaping the clinical approach to leukemia and other blood cancers. His research supports the development of therapies that are not only effective but also accessible, offering hope to patients through more precise and responsive interventions. As one expert recommendation stated:

“In conclusion, [client]’s skillset and contributions to the field are irreplaceable, given the immense benefits of her acute myeloid leukemia to healthcare treatment availabilities in the United States and beyond. It is essential that he be allowed to carry out his research without interruption so that the United States can fully benefit from its value.”

Academic Contributions and Recognition

➢ 9 peer-reviewed journal articles, including 3 first- or co-first-authored, 2 abstracts

➢ 1 granted patent

➢ 39 total citations

➢ At least 25 completed peer reviews

➢ Research funded by the National Natural Science Foundation of China (NSFC)

Seamless Legal Strategy with NAILG

To advance his groundbreaking work in the United States, our client partnered with the North America Immigration Law Group (NAILG) to file his National Interest Waiver (NIW) petition. Drawing on deep expertise in immigration law for researchers and clinicians, NAILG crafted a customized legal strategy that emphasized his unique qualifications, real-world clinical impact, and contributions to public health. By aligning his achievements with national priorities in cancer treatment and biomedical innovation, NAILG presented a compelling case that led to swift NIW approval, clearly affirming his value to the U.S. medical research ecosystem.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.